Market Recap — October 23, 2026
Recap of insider activity, SEC filings, and market-moving news for October 23, 2026.
Last generated Nov 2, 2026, 10:53 PM ET
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Circle8's Lyneer Unit Hit With PEO Default, SPP Default Notice and a Scheduled UCC Asset Sale
House of Doge Signs $15M McQueen Labs LOI, Resets Dogecoin License, Swaps CEO and CFO
Century Casinos Receives Nasdaq Deficiency Notice Over $35M Market Value Requirement
Instacart Explores Sale After Preliminary Talks With DoorDash, Uber
REE Automotive Secures $4M Lifeline; Existing Shareholders Wiped Out in Restructuring
Povetacicept Cuts Proteinuria 49.8% in Phase 3 IgAN Trial, FDA Decision Due Nov. 30
Phase 3 Win: Rina-S Cuts Ovarian Cancer Progression Risk 71%, Extends Survival
Bolt Buys Prana Therapies, Raises $120M to Fund PRA-216
Arcosa Closes $150/Share CRH Merger; ~$7.5B Paid, Shares Delisted
Elicio's Lead Cancer Vaccine Misses Primary Endpoint in Phase 2 Trial
LKQ Ousts CEO Jude, Warns Q3 EPS Will Miss Badly as Europe Crumbles
LKQ Ousts CEO Jude, Withdraws 2026 Guidance After $111M Europe Impairment
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Circle8's Lyneer Unit Hit With PEO Default, SPP Default Notice and a Scheduled UCC Asset Sale
House of Doge Signs $15M McQueen Labs LOI, Resets Dogecoin License, Swaps CEO and CFO
Century Casinos Receives Nasdaq Deficiency Notice Over $35M Market Value Requirement
Instacart Explores Sale After Preliminary Talks With DoorDash, Uber
Povetacicept Cuts Proteinuria 49.8% in Phase 3 IgAN Trial, FDA Decision Due Nov. 30
Phase 3 Win: Rina-S Cuts Ovarian Cancer Progression Risk 71%, Extends Survival
Bolt Buys Prana Therapies, Raises $120M to Fund PRA-216
Arcosa Closes $150/Share CRH Merger; ~$7.5B Paid, Shares Delisted
Elicio's Lead Cancer Vaccine Misses Primary Endpoint in Phase 2 Trial
LKQ Ousts CEO Jude, Warns Q3 EPS Will Miss Badly as Europe Crumbles
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.